UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 229

Sortiert nach

Comparisons of Food and Drug Administration and European Medicines Agency Risk Management Implementation for Recent Pharmaceutical Approvals: Report of the International Society for Pharmacoeconomics and Outcomes Research Risk Benefit Management Working Group

Value in health, 2012-12, Vol.15 (8), p.1108-1118

2012

Volltextzugriff (PDF)

A Review of Quantitative Risk–Benefit Methodologies for Assessing Drug Safety and Efficacy—Report of the ISPOR Risk–Benefit Management Working Group

Value in health, 2010-08, Vol.13 (5), p.657-666

2010

Volltextzugriff (PDF)

Economic burden and treatment patterns of gynecologic cancers in the United States: evidence from the Medical Expenditure Panel Survey 2007-2014

Journal of Gynecologic Oncology, 2020, 31(4), , pp.1-13

2020

Volltextzugriff (PDF)

Descriptive Analysis of Adverse Events Reported for New Multiple Myeloma Medications Using FDA Adverse Event Reporting System (FAERS) Databases from 2015 to 2022

Pharmaceuticals (Basel, Switzerland), 2024-06, Vol.17 (7), p.815

2024

Volltextzugriff (PDF)

Utilization, reimbursement, and price trends for Hepatitis C virus medications in the US Medicaid programs: 2001-2021

Exploratory research in clinical and social pharmacy, 2023-12, Vol.12, p.100383-100383, Article 100383

2023

Volltextzugriff (PDF)

A Process for Measuring the Quality of Cancer Care: The Quality Oncology Practice Initiative

Journal of clinical oncology, 2005-09, Vol.23 (25), p.6233-6239

2005

Volltextzugriff (PDF)

Smoking in pregnancy: a cross-sectional study in China

Tobacco induced diseases, 2017-07, Vol.15 (1), p.35-35, Article 35

2017

Volltextzugriff (PDF)

Current Development and Practice of Pharmacoeconomic Evaluation Guidelines for Universal Health Coverage in China

Value in health regional issues, 2021-05, Vol.24, p.1-5

2021

Volltextzugriff (PDF)

Type 2 Diabetes Mellitus in Youth Exposed to Antipsychotics: A Systematic Review and Meta-analysis

JAMA psychiatry (Chicago, Ill.), 2016-03, Vol.73 (3), p.247

2016

Volltextzugriff (PDF)

China's first rare-disease registry is under development

The Lancet (British edition), 2011-08, Vol.378 (9793), p.769-770

2011

Volltextzugriff (PDF)

Safety and cost-effectiveness of ponatinib versus other tyrosine kinase inhibitors as second-line therapy in patients with chronic myeloid leukemia in the United States

Leukemia & lymphoma, 2022-03, Vol.63 (4), p.946-954

2022

Volltextzugriff (PDF)

A novel online survey approach designed to measure consumer sunscreen application thickness—implications for estimating environmental emissions

Journal of exposure science & environmental epidemiology, 2023-10

2023

Volltextzugriff (PDF)

Treatment of obesity: Pharmacotherapy trends in the United States from 1999 to 2010

Obesity (Silver Spring, Md.), 2015-08, Vol.23 (8), p.1721-1728

2015

Volltextzugriff (PDF)

Racial/Ethnic and Socioeconomic Disparities and Self-reported Work Productivity in Urinary Incontinence Females Using the National Institute of Diabetes and Digestive and Kidney Diseases Data

Urology (Ridgewood, N.J.), 2024-06

2024

Volltextzugriff (PDF)

The Utilization, Expenditure, and Price of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the US Medicaid Programs: Trends Over a 31 Year Period

International journal of cardiology, 2023-01, Vol.370, p.412-418

2023

Volltextzugriff (PDF)

Trends in the Utilization of, Spending on, and Prices for Outpatient Antifungal Agents in US Medicaid Programs: 1991–2009

Clinical therapeutics, 2012-10, Vol.34 (10), p.2118-2131.e1

2012

Volltextzugriff (PDF)

Comparative effectiveness and persistence of TNFi and non-TNFi in juvenile idiopathic arthritis: a large paediatric rheumatology centre in the USA

Rheumatology (Oxford, England), 2021-09, Vol.60 (9), p.4063-4073

2021

Volltextzugriff (PDF)

Risk of serious asthma exacerbations associated with long-acting beta agonists among patients with asthma: A retrospective cohort study

Annals of allergy, asthma, & immunology, 2011-03, Vol.106 (3), p.214-222.e2

2011

Volltextzugriff (PDF)

Factors Associated with Statin Discontinuation Following Metabolic and Bariatric Surgery: A Retrospective Analysis of 2012–2021 Electronic Medical Records Network Data

Obesity surgery, 2024-04, Vol.34 (4), p.1267-1278

2024

Volltextzugriff (PDF)

Utilization, price, and spending trends for antidepressants in the US Medicaid program

Research in social and administrative pharmacy, 2008-09, Vol.4 (3), p.244-257

2008

Volltextzugriff (PDF)

Real‐World Evidence: What It Is and What It Can Tell Us According to the International Society for Pharmacoepidemiology (ISPE) Comparative Effectiveness Research (CER) Special Interest Group (SIG)

Clinical pharmacology and therapeutics, 2018-08, Vol.104 (2), p.239-241

2018

Volltextzugriff (PDF)

Treatment Costs and Health Care Utilization for Patients with Bipolar Disorder in a Large Managed Care Population

Value in health, 2008-05, Vol.11 (3), p.416-423

2008

Volltextzugriff (PDF)

Biologic Disease-Modifying Antirheumatic Drugs in a National, Privately Insured Population: Utilization, Expenditures, and Price Trends

American health & drug benefits, 2017-02, Vol.10 (1), p.27-36

2017

Volltextzugriff (PDF)

Off-label medication use in rare pediatric diseases in the United States

Intractable & Rare Diseases Research, 2021/11/30, Vol.10(4), pp.238-245

2021

Volltextzugriff (PDF)

Preventive behaviours in avoiding indoor secondhand smoke exposure among pregnant women in China

Tobacco control, 2017-07, Vol.26 (4), p.483

2017

Volltextzugriff (PDF)

1 – 25 von 229

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(191)
Mit Volltextzugriff
(196)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Comparisons of Food and Drug Administration and European Medicines Agency Risk Management Implementation for Recent Pharmaceutical Approvals: Report of the International Society for Pharmacoeconomics and Outcomes Research Risk Benefit Management Working Group

A Review of Quantitative Risk–Benefit Methodologies for Assessing Drug Safety and Efficacy—Report of the ISPOR Risk–Benefit Management Working Group

Economic burden and treatment patterns of gynecologic cancers in the United States: evidence from the Medical Expenditure Panel Survey 2007-2014

Descriptive Analysis of Adverse Events Reported for New Multiple Myeloma Medications Using FDA Adverse Event Reporting System (FAERS) Databases from 2015 to 2022

Utilization, reimbursement, and price trends for Hepatitis C virus medications in the US Medicaid programs: 2001-2021

A Process for Measuring the Quality of Cancer Care: The Quality Oncology Practice Initiative

Smoking in pregnancy: a cross-sectional study in China

Current Development and Practice of Pharmacoeconomic Evaluation Guidelines for Universal Health Coverage in China

Type 2 Diabetes Mellitus in Youth Exposed to Antipsychotics: A Systematic Review and Meta-analysis

China's first rare-disease registry is under development

Safety and cost-effectiveness of ponatinib versus other tyrosine kinase inhibitors as second-line therapy in patients with chronic myeloid leukemia in the United States

A novel online survey approach designed to measure consumer sunscreen application thickness—implications for estimating environmental emissions

Treatment of obesity: Pharmacotherapy trends in the United States from 1999 to 2010

Racial/Ethnic and Socioeconomic Disparities and Self-reported Work Productivity in Urinary Incontinence Females Using the National Institute of Diabetes and Digestive and Kidney Diseases Data

The Utilization, Expenditure, and Price of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the US Medicaid Programs: Trends Over a 31 Year Period

Trends in the Utilization of, Spending on, and Prices for Outpatient Antifungal Agents in US Medicaid Programs: 1991–2009

Comparative effectiveness and persistence of TNFi and non-TNFi in juvenile idiopathic arthritis: a large paediatric rheumatology centre in the USA

Risk of serious asthma exacerbations associated with long-acting beta agonists among patients with asthma: A retrospective cohort study

Factors Associated with Statin Discontinuation Following Metabolic and Bariatric Surgery: A Retrospective Analysis of 2012–2021 Electronic Medical Records Network Data

Utilization, price, and spending trends for antidepressants in the US Medicaid program

Real‐World Evidence: What It Is and What It Can Tell Us According to the International Society for Pharmacoepidemiology (ISPE) Comparative Effectiveness Research (CER) Special Interest Group (SIG)

Treatment Costs and Health Care Utilization for Patients with Bipolar Disorder in a Large Managed Care Population

Biologic Disease-Modifying Antirheumatic Drugs in a National, Privately Insured Population: Utilization, Expenditures, and Price Trends

Off-label medication use in rare pediatric diseases in the United States

Preventive behaviours in avoiding indoor secondhand smoke exposure among pregnant women in China

Suchergebnisse filtern